These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U; J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408 [TBL] [Abstract][Full Text] [Related]
10. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes. Trotter JF; Osgood MJ JAMA; 2004 Apr; 291(15):1871-4. PubMed ID: 15100206 [TBL] [Abstract][Full Text] [Related]
11. Liver Transplantation with "Hors Tour" Allocated Versus Standard MELD Allocated Grafts: Single-Center Audit and Impact on the Liver Pool in France. Azoulay D; Disabato M; Gomez-Gavara C; Feray C; Salloum C; Ngonggang N; Winter A; Hentati H; Levesque E; Lim C; Compagnon P World J Surg; 2020 Mar; 44(3):912-924. PubMed ID: 31832704 [TBL] [Abstract][Full Text] [Related]
12. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry. Schlansky B; Chen Y; Scott DL; Austin D; Naugler WE Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of kidney grafts refused by one or more centers and subsequently transplanted at a single United Kingdom center. Farid S; Aldouri A; Fraser S; Al-Mukhtar A; Newstead C; Lewington A; Baker R; Menon K; Ahmad N Transplant Proc; 2009 Jun; 41(5):1541-6. PubMed ID: 19545675 [TBL] [Abstract][Full Text] [Related]
14. Management of liver transplantation waiting list for decompensated cirrhosis in a Spanish tertiary hospital: differences between hepatitis C virus recipients and other etiologies. Ibáñez Samaniego L; Pérez Valderas M; Fernández Yunquera A; Rincón Rodríguez D; López Baena JA; Matilla Peña A; Catalina Rodríguez MV; Clemente Ricote G; Bañares Cañizares R; Salcedo Plaza M Transplant Proc; 2014 Nov; 46(9):3084-6. PubMed ID: 25420829 [TBL] [Abstract][Full Text] [Related]
16. Prospective validation of a new priority allocation model for liver transplant candidates: an interim analysis. Vitale A; Saracino E; D'Amico FE; Grigoletto F; Burra P; Angeli P; Boccagni P; Brolese A; Zanus G; Neri D; Gringeri E; D'Amico F; Valmasoni M; Carraro A; Gambato M; Feltracco P; Romano A; Buggio M; D'Amico DF; Cillo U Transplant Proc; 2009 May; 41(4):1092-5. PubMed ID: 19460489 [TBL] [Abstract][Full Text] [Related]
17. Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation. Goldaracena N; Gorgen A; Doyle A; Hansen BE; Tomiyama K; Zhang W; Ghanekar A; Lilly L; Cattral M; Galvin Z; Selzner M; Bhat M; Selzner N; McGilvray I; Greig PD; Grant DR; Sapisochin G J Hepatol; 2019 Apr; 70(4):666-673. PubMed ID: 30630009 [TBL] [Abstract][Full Text] [Related]
18. Proposal of a novel MELD exception point system for hepatocellular carcinoma based on tumor characteristics and dynamics. Bhat M; Ghali P; Dupont B; Hilzenrat R; Tazari M; Roy A; Chaudhury P; Alvarez F; Carrier M; Bilodeau M J Hepatol; 2017 Feb; 66(2):374-381. PubMed ID: 27751840 [TBL] [Abstract][Full Text] [Related]
19. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease. Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678 [TBL] [Abstract][Full Text] [Related]